Why This Seattle Biotech Could be an M&A Target Post author:Sam Post published:January 18, 2018 Post category:BioPharma Immune Design is a clinical-stage immunotherapy company. Source: BioSpace You Might Also Like Alzheon Launches IPO to Fund Alzheimer's Drug March 18, 2018 GlaxoSmithKline Is Taking a Tough Approach to Budgets March 20, 2018 It's Official: Shire Takes Over Ariad's Old Space in Kendall Square October 8, 2017
